“Clinical trials of a vaccine will compete with mass vaccinations.

Therefore, the companies that were the first to enter the vaccine race have the greatest chances to get an accurate idea of ​​the effectiveness of their vaccines, ”RIA Novosti quotes Baranova.

Clinical trials of vaccines will soon become very difficult, she said.

She noted that people receiving placebo during trials will want to be vaccinated when mass vaccinations begin.

Earlier, Moscow Mayor Sergei Sobyanin, on the air of the Russia 24 channel, announced the readiness of the city's infrastructure to carry out mass vaccination of the population against COVID-19 coronavirus infection.